Dr. Mark A. Schattner, MD

Dr. Schattner practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Schattner's NPI, 1063483907, was assigned on January 30, 2006. Dr. Schattner graduated from Perelman School of Medicine - Philadelphia in 1995. Dr. Schattner holds New York license 205323.

Dr. Schattner's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Schattner's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Monmouth. Dmand AI also links Dr. Schattner to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schattner practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Schattner's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Schattner is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Schattner's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists acid reflux, colonoscopy, intestinal or bowel obstruction, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Schattner treats.

CMS data shows 774 Medicare services from Dr. Schattner across 17 procedure codes in 2024, for 556 Medicare patients. Medicare paid $96,910 for them.

CMS counts 556 Medicare patients who saw Dr. Schattner in 2024. The largest group is 65 to 74, with 254 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schattner's median patient age at 72, with 51% women.

In 2024, Dr. Schattner wrote 495 Medicare Part D claims for 159 patients. 79% of them were for generic drugs. CMS names the drug for 378 of them, across 8 drugs with 11 or more claims each, at $132,211 in total drug cost. In 2023, CMS named 364 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Schattner for performance year 2024, reported as part of a group. Dr. Schattner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schattner as offering telehealth. CMS counts 554 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Schattner, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 96 papers to Dr. Schattner, published from 2008 to 2025. 2017 was the busiest year, with 8. The most frequent topics are Stomach Neoplasms, Adenocarcinoma and Pancreatic Neoplasms. Dr. Schattner has published most often in Gastrointest Endosc. Dr. Schattner's most frequent co-authors are Hans Gerdes, MD, Arnold J. Markowitz, MD and Vivian E. Strong, MD.

Dmand AI links Dr. Schattner to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Pancreatic Neoplasms and Pancreatic Diseases. Memorial Sloan Kettering Cancer Center sponsors the most, 2.

CMS Open Payments shows 57 general payments to Dr. Schattner from 3 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $42,140. It also lists 18 research payments totaling $69,762 from 2020 to 2023.

Dmand AI lists 1 award for Dr. Schattner.

Dr. Schattner graduated from Perelman School of Medicine - Philadelphia in 1995.

Dr. Schattner is in network with 10 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.